IL31 and Miyoshi myopathy: group versus the MM group: IL-31 (Sev.: 125.99 [91.58–173.85] pg/mL vs. MM: 65.14 [51.27–85.47] pg/mL; p < 0.0001) and IL-5 (Sev.: 3.84 [1.57–10.63] pg/mL vs. MM: 1.35 [0.83–2.93] pg/mL; p < 0.001); this comparative profile is presented in Figure 2.